The revenue beat is overshadowed by the guidance reduction and declining operating cash flow. Traders should monitor the Q3 2026 earnings call for clarity on Medicaid program renewals and margin trajectory; the stock's poor recent T+20 drift suggests fading any initial bounce.
Price Chart
Executive Summary
UHS reported Q2 2026 GAAP EPS of $5.98, a slight miss vs. the $6.01 consensus, while revenue of $4.638B beat the $4.58B estimate. The company revised its full-year 2026 Adjusted EPS guidance downward to a midpoint of $22.97 from $23.58, and lowered its Adjusted EBITDA midpoint by 1.9%, signaling margin pressure despite top-line growth. The stock's negative historical drift on prior reports (avg -10.64% T+20) and the guidance cut outweigh the revenue beat, making this a bearish read-through for traders.
Key Financial Metrics
Key Facts
- Q2 2026 GAAP EPS $5.98 vs consensus $6.01 (-0.4% miss)
- Q2 2026 net revenues $4.638B vs consensus $4.58B (+1.3% beat)
- Revenue grew 8.3% YoY to $4.638B from $4.284B
- Full-year 2026 Adjusted EPS guidance lowered to $22.28-$23.65 (midpoint $22.97) from $22.64-$24.52 (midpoint $23.58)
- Full-year 2026 Adjusted EBITDA midpoint lowered 1.9% to ~$2.663B from ~$2.715B
- Q2 included a favorable $100M pre-tax impact from Florida Medicaid program (not in original forecast)
- Operating cash flow for H1 2026 was $845M, down from $909M in H1 2025
- Repurchased 1.89M shares for ~$320M in Q2 2026
Financial Impact
Guidance cut of ~2.6% on Adjusted EPS midpoint ($23.58 → $22.97) and ~1.9% on Adjusted EBITDA midpoint ($2.715B → $2.663B)
Risk Factors
- Florida Medicaid directed payment program not yet approved beyond Sep 2025 — no incremental benefit in H2 2026 forecast
- Operating cash flow declined 7% YoY in H1 2026 ($845M vs $909M)
- Adjusted EBITDA margin contracted to 14.5% from 14.8% in H1 2026 vs H1 2025
- Legislative risk from work requirements and provider fee limits on Medicaid
- Pending Talkspace acquisition adds integration and execution risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302835623 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | 8-K | $177.26 $176.69 | ▼ −0.32% | ▼ −0.04% | $174.49 (−1.57%) |
Jul 27, 2026 9w ago | Press Release | $166.22 $175.66 | ▼ −5.68% | ▼ −2.30% | $174.49 (−4.97%) |
May 21, 2026 19w ago | 8-K | $162.28 $141.17 | ▼ −13.01% | ▼ −13.55% | $174.49 (+7.52%) |
Apr 24, 2026 23w ago | 8-K | $173.78 $162.45 | ▼ −6.52% | ▼ −10.55% | $174.49 (+0.41%) |
Apr 9, 2026 25w ago | DEFA14A | $187.57 $168.49 | ▼ −10.17% | ▼ −17.74% | $174.49 (−6.98%) |
Feb 26, 2026 31w ago | 8-K | $203.26 $185.07 | ▼ −8.95% | ▼ −2.55% | $174.49 (−14.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access